Miguel C. Jansen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Miguel C. Jansen has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Annelies de Klein
Department of Clinical Genetics, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands
1 shared publication Caroline A. Hundepool
Department of Plastic, Reconstructive Surgery and Hand Surgery, Erasmus Medical Centre, Rotterdam, The Netherlands
1 shared publication- Dion Paridaens
Department of Oculoplastic & Orbital Surgery The Rotterdam Eye Hospital & Erasmus Medical Center Rotterdam
1 shared publication Dominic M. Power
Queen Elizabeth Hospital Birmingham, Birmingham Hand Centre, Birmingham, United Kingdom
1 shared publication- Emine Kiliç
Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, The Netherlands
1 shared publication - Erwin Brosens
Department of Clinical Genetics Erasmus MC Cancer Institute University Medical Center Rotterdam The Netherlands
1 shared publication
Latest Publications
- 1 April 2022
- Published by Elsevier in The Journal of Hand Surgery
- Vol. 47 (4) , 388.e1-388.e19
Management of Recurrent Carpal Tunnel Syndrome: Systematic Review and Meta-Analysis
- 1 April 2022
- Published by Elsevier in The Journal of Hand Surgery
- Vol. 47 (4) , 388.e1-388.e19
Management of Recurrent Carpal Tunnel Syndrome: Systematic Review and Meta-Analysis
- Open Access
Radiological Patterns of Uveal Melanoma Liver Metastases in Correlation to Genetic Status
This study reports the role played by the mutation status of Uveal Melanoma (UM) in relation to hepatic metastatic patterns as seen on imaging modalities. Radiological images were obtained from 123 patients treated at the Erasmus Medical Center Rotterdam or the Rotterdam Eye Hospital. Radiological images were derived from either computed tomography or magnetic resonance imaging. Hepatic metastatic patterns were classified by counting the number of metastases found in the liver. Miliary metastatic pattern (innumerable small metastases in the entire liver) was analyzed separately. Mutation status was determined in 85 patients. Median disease-free survival (DFS) and survival with metastases differed significantly between each of the metastatic patterns (respectively, p = 0.009, p < 0.001), both in favor of patients with less hepatic metastases. The mutation status of the primary tumor was not correlated with any hepatic tumor profiles (p = 0.296). Of the patients who had a solitary metastasis (n = 18), 11 originated from a primary BAP1-mutated tumors and one from a primary SF3B1-mutated tumor. Of the patients who had a miliary metastasis pattern (n = 24), 17 had a primary BAP1-mutated tumor and two had a primary SF3B1-mutated tumor. Chromosome 8p loss was significantly more in patients with more metastases (p = 0.045). Moreover, the primary UMs of patients with miliary metastases harbored more chromosome 8p and 1p loss, compared to patients with single solitary metastasis (p = 0.035 and p = 0.026, respectively). In conclusion, our study shows that there is an inverse correlation of the number of metastasis with the DFS and metastasized survival, indicating separate growth patterns. We also revealed that the number and type of metastases is irrelevant to the prognostic mutation status of the tumor, showing that both BAP1- and SF3B1-mutated UM can result in solitary and miliary metastases, indicating that other processes lay ground to the different metastatic patterns.
Open AccessRadiological Patterns of Uveal Melanoma Liver Metastases in Correlation to Genetic Status
This study reports the role played by the mutation status of Uveal Melanoma (UM) in relation to hepatic metastatic patterns as seen on imaging modalities. Radiological images were obtained from 123 patients treated at the Erasmus Medical Center Rotterdam or the Rotterdam Eye Hospital. Radiological images were derived from either computed tomography or magnetic resonance imaging. Hepatic metastatic patterns were classified by counting the number of metastases found in the liver. Miliary metastatic pattern (innumerable small metastases in the entire liver) was analyzed separately. Mutation status was determined in 85 patients. Median disease-free survival (DFS) and survival with metastases differed significantly between each of the metastatic patterns (respectively, p = 0.009, p < 0.001), both in favor of patients with less hepatic metastases. The mutation status of the primary tumor was not correlated with any hepatic tumor profiles (p = 0.296). Of the patients who had a solitary metastasis (n = 18), 11 originated from a primary BAP1-mutated tumors and one from a primary SF3B1-mutated tumor. Of the patients who had a miliary metastasis pattern (n = 24), 17 had a primary BAP1-mutated tumor and two had a primary SF3B1-mutated tumor. Chromosome 8p loss was significantly more in patients with more metastases (p = 0.045). Moreover, the primary UMs of patients with miliary metastases harbored more chromosome 8p and 1p loss, compared to patients with single solitary metastasis (p = 0.035 and p = 0.026, respectively). In conclusion, our study shows that there is an inverse correlation of the number of metastasis with the DFS and metastasized survival, indicating separate growth patterns. We also revealed that the number and type of metastases is irrelevant to the prognostic mutation status of the tumor, showing that both BAP1- and SF3B1-mutated UM can result in solitary and miliary metastases, indicating that other processes lay ground to the different metastatic patterns.